Demonstrates improved luminescent properties in Cu-doped perovskite nanoplates, suggesting effective defect regulation.
All-inorganic lead halide perovskites (CsPbX 3 ) have attracted extensive attention due to their outstanding optoelectronic properties; however, their practical applications are severely limited by structural instability and defect-induced nonradiative recombination. Herein, we report a kinetically controllable hot-injection strategy to synthesize Cu 2+ -doped CsPbI 3 nanoplates (NPLs). By precisely regulating the injection timing and amount of hydroiodic acid, a critical balance nucleation and growth is established, enabling the formation of uniform NPLs. Structural analysis confirms successful incorporation of Cu 2+ into the CsPbI 3 lattice without phase transition, accompanied by slight lattice contraction. Importantly, Cu 2+ doping does not significantly change the bandgap but effectively reduces defect density, as evidenced by decreased Urbach energy and prolonged carrier lifetime. As a result, the photoluminescence quantum yield is maximized at an optimal doping level of 10%, reflecting effective defect suppression. Time-resolved photoluminescence further reveals suppressed nonradiative recombination and improved carrier dynamics. Moreover, the doped NPLs exhibit significantly enhanced stability, retaining ∼82% of their initial PL intensity after 20 days, compared to ∼8% for pristine samples. Overall, this work provides an effective strategy for simultaneously improving the luminescence performance and environmental stability of perovskite nanomaterials through defect engineering.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: